Metropolis Healthcare has expanded into new service areas, like Clinical Research, Hospital Lab Management and Wellness Solutions, in the past decade.

In February 2018, Metropolis partnered with National Aids Control Organisation (NACO) for a three-year project for diagnosis of HIV at 560 locations in India.

[13][14] As of 2018, the diagnostic chain consists of 124 clinical laboratories and 2400 blood collection centers[5][7] across India, Ghana, Kenya, Zambia, Uganda, Mauritius and Sri Lanka.

[20] The company is backed by several investors including Carlyle Group, CA Lotus Investments[21] and Kohlberg Kravis Roberts (KKR).

[24] In 2014, it was awarded India's Most Promising Brand by the World Consulting and Research Corporation, which was evaluated by Ernst & Young.

[29] In April 2017, Metropolis launched a scholarship and mentorship program, called "Medengage", for undergraduate and postgraduate medical students across India.